How to protect PrEP coverage, no matter what happens in Braidwood v. Becerra
This move could avert disruption to PrEP access for millions of Americans.
Related Articles
What it’s like to have measles, mumps, whooping cough, and other vaccine-preventable illnesses
STAT readers share what it’s link to have measles, mumps, whooping cough, and other vaccine-preventable illnesses. Some stories are from decades past — others are…
As Trump attacks on Harvard gain momentum, researchers scramble: ‘Everyone can read the writing on the wall’
As Trump attacks on Harvard gain momentum, researchers are scrambling: “Everyone can read the writing on the wall.”
Five burning questions about FDA’s ‘aggressive’ deployment of AI for scientific review
FDA’s plan to deploy an AI tool to assist with scientific review process raises questions about transparency and risks.
Here’s how Trump might approach his drug pricing plan
President Trump is expected to advance a “most-favored nation” policy to lower drug prices. How effective might it be? The devil will be in the…
STAT Summit West
Discover the impact of AI and emerging tech on health innovation Register now ABOUT BREAKTHROUGH WEST In Medicine, Artificial Intelligence Gets Real Yes,
Insitro, an AI biotech founded by Daphne Koller, lays off staff
Insitro, an AI biotech founded by Daphne Koller, lays off staff as pressure builds for it to launch clinical trials of new drugs.
Up and down the ladder: The latest comings and goings
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.
FDA approves Verastem’s ovarian cancer treatment
And more biotech news, brought to you by The Readout.
Pharmalittle: We’re reading about a Trump drug-pricing plan, an AstraZeneca court loss, and more
House Republicans are considering nixing a Medicaid drug-pricing plan floated by President Trump and fiercely opposed by pharma